|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7000 MYR | 0.00% |
|
+1.45% | +1.45% |
| Market Cap | 155M 38.08M 33.29M 30.71M 28.23M 53.49M 3.66B 54.41M 367M 144M 1.79B 143M 140M 6.17B | P/E 2026 * |
9.94x | P/E 2027 * | 9.41x |
|---|---|---|---|---|---|
| Enterprise Value | 155M 38.08M 33.29M 30.71M 28.23M 53.49M 3.66B 54.41M 367M 144M 1.79B 143M 140M 6.17B | EV / Sales 2026 * |
0.64x | EV / Sales 2027 * | 0.59x |
| Free-Float |
14.34% | Yield 2026 * |
3.57% | Yield 2027 * | 3.86% |
| 1 week | +1.45% | ||
| Current month | +4.48% | ||
| 1 month | +5.26% | ||
| 3 months | +6.87% | ||
| 6 months | +1.45% | ||
| Current year | +1.45% |
| 1 week | 0.68 | 0.7 | |
| 1 month | 0.64 | 0.7 | |
| Current year | 0.62 | 0.72 | |
| 1 year | 0.61 | 0.74 | |
| 3 years | 0.58 | 0.8 | |
| 5 years | 0.58 | 0.8 | |
| 10 years | 0.57 | 1.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ban Keong Lim
CEO | Chief Executive Officer | 55 | 2015-03-31 |
Yan San Chan
DFI | Director of Finance/CFO | 56 | 2013-12-31 |
| Chief Operating Officer | 38 | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 77 | 2015-03-31 | |
Ban Keong Lim
BRD | Director/Board Member | 55 | 2015-03-31 |
Kam Weng Foong
BRD | Director/Board Member | 66 | 2015-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-01-30 | Buy | Chief Executive Officer | 110,000 | 0.0497% | ||
| 23-09-21 | Buy | Chief Executive Officer | 17,000 | 0.0077% | ||
| 23-09-07 | Buy | Chief Executive Officer | 103,000 | 0.0466% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +1.45% | +13.82% | -0.71% | 38.08M | ||
| +0.35% | -6.39% | +44.70% | +157.34% | 1,028B | ||
| -2.69% | -7.57% | +57.52% | +54.51% | 611B | ||
| +0.44% | -4.14% | +27.46% | +79.48% | 432B | ||
| +0.98% | -2.74% | +28.13% | +21.76% | 323B | ||
| -0.34% | -3.79% | +26.52% | +43.60% | 277B | ||
| +1.63% | -12.52% | +17.86% | +21.72% | 257B | ||
| +3.39% | +0.95% | -25.43% | -37.83% | 217B | ||
| +0.86% | -2.66% | +20.63% | +57.55% | 192B | ||
| +1.28% | -3.42% | +17.49% | +70.62% | 161B | ||
| Average | +0.59% | -4.72% | +22.87% | +46.80% | 349.84B | |
| Weighted average by Cap. | +0.19% | -5.52% | +32.95% | +76.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 244M 59.73M 52.22M 48.17M 44.28M 83.9M 5.75B 85.34M 575M 226M 2.81B 224M 219M 9.68B | 265M 65.05M 56.87M 52.46M 48.23M 91.38M 6.26B 92.94M 626M 246M 3.06B 244M 239M 10.54B |
| Net income | 15.6M 3.82M 3.34M 3.08M 2.84M 5.37M 368M 5.47M 36.83M 14.45M 180M 14.36M 14.05M 620M | 15.6M 3.82M 3.34M 3.08M 2.84M 5.37M 368M 5.47M 36.83M 14.45M 180M 14.36M 14.05M 620M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-15 | MYR 0.7000 | 0.00% | 66,000 |
| 26-07-14 | MYR 0.7000 | +1.45% | 130,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 5278 Stock
Select your edition
All financial news and data tailored to specific country editions
















